Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3196 AL 3210

Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier

Semyachkina-Glushkovskaya O, Postnov D, Penzel T, Kurths J.

Int J Mol Sci. 2020 Aug 31;21(17):6293. doi: 10.3390/ijms21176293.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients

Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease

Gustavsson A, Pemberton-Ross P, Gomez Montero M, Hashim M, Thompson R.

Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):563-570. doi: 10.1080/14737167.2020.1822738. Epub 2020 Sep 20.

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI).

Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3.

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Breijyeh Z, Karaman R.

Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

Pharmacogenetic studies in Alzheimer disease

Zúñiga Santamaría T, Yescas Gómez P, Fricke Galindo I, González González M, Ortega Vázquez A, López López M.

Neurologia (Engl Ed). 2022 May;37(4):287-303. doi: 10.1016/j.nrleng.2018.03.022. Epub 2020 Jun 1.

A Scoping Review of Physical Performance Outcome Measures Used in Exercise Interventions for Older Adults With Alzheimer Disease and Related Dementias

McGough EL, Lin SY, Belza B, Becofsky KM, Jones DL, Liu M, Wilcox S, Logsdon RG.

J Geriatr Phys Ther. 2019 Jan/Mar;42(1):28-47. doi: 10.1519/JPT.0000000000000159.

Neuroprotective Effects of Flavonoid Compounds on Neuronal Death Associated to Alzheimer's Disease

Sureda A, Capó X, Tejada S.

Curr Med Chem. 2019;26(27):5124-5136. doi: 10.2174/0929867325666171226103237.

Aerobic Exercise Sustains Performance of Instrumental Activities of Daily Living in Early-Stage Alzheimer Disease

Vidoni ED, Perales J, Alshehri M, Giles AM, Siengsukon CF, Burns JM.

J Geriatr Phys Ther. 2019 Jul/Sep;42(3):E129-E134. doi: 10.1519/JPT.0000000000000172.

Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review

da Costa IM, Freire MAM, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, Moreira Rosa IMM, de Azevedo EP, do Rego ACM, Filho IA, Guzen FP.

Curr Neuropharmacol. 2019;17(5):406-421. doi: 10.2174/0929867325666180117112610.

Therapeutic Potential of Multifunctional Tacrine Analogues

Przybyłowska M, Kowalski S, Dzierzbicka K, Inkielewicz-Stepniak I.

Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908.

Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview

Baheti K, Kale M.

Curr Drug Discov Technol. 2019;16(1):66-73. doi: 10.2174/1570163815666180417120833.

Viral Induced Oxidative and Inflammatory Response in Alzheimer's Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach

Talwar P, Gupta R, Kushwaha S, Agarwal R, Saso L, Kukreti S, Kukreti R.

Curr Neuropharmacol. 2019;17(4):352-365. doi: 10.2174/1570159X16666180419124508.

Drugs for Targeted Therapies of Alzheimer's Disease

Tam C, Wong JH, Ng TB, Tsui SKW, Zuo T.

Curr Med Chem. 2019;26(2):335-359. doi: 10.2174/0929867325666180430150940.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias